Atherosclerosis is not merely a disease of the circulation and vasculature. The process receives profound contributions from inflammatory mechanisms [1] , and low-grade inflammation is present among individuals at risk for future atherothrombotic disease. Specifically, elevated levels of inflammatory markers [2, 3] have been found to be associated with risk for developing coronary events and symptomatic peripheral arterial disease [4, 5] . Furthermore, early work that evaluated the white blood cell (WBC) count as a predictor of vascular events confirmed that WBC counts in the highnormal range confer a significant risk for future myocardial infarction [6] and stroke [7] . Our own work in critical limb ischaemia [8] also showed the WBC count to predict those destined for future amputation. Evidence indicated that for each 1·0 × 10 9 .l -1 cell difference there was a 32% increase in cardiovascular disease risk for men and 17% for women [9] . The WBC may contribute to vascular disease in the patient with claudication through both physical and chemical means.
Introduction
Atherosclerosis is not merely a disease of the circulation and vasculature. The process receives profound contributions from inflammatory mechanisms [1] , and low-grade inflammation is present among individuals at risk for future atherothrombotic disease. Specifically, elevated levels of inflammatory markers [2, 3] have been found to be associated with risk for developing coronary events and symptomatic peripheral arterial disease [4, 5] . Furthermore, early work that evaluated the white blood cell (WBC) count as a predictor of vascular events confirmed that WBC counts in the highnormal range confer a significant risk for future myocardial infarction [6] and stroke [7] . Our own work in critical limb ischaemia [8] also showed the WBC count to predict those destined for future amputation. Evidence indicated that for each 1·0 × 10 9 .l -1 cell difference there was a 32% increase in cardiovascular disease risk for men and 17% for women [9] . The WBC may contribute to vascular disease in the patient with claudication through both physical and chemical means.
Physical mechanisms
Physically, the WBC can impair the microvascular circulation by aggregating both to itself and to other cells, thus forming microemboli, which may cause circulatory disturbances in remote organs [10] . We developed a technique that can assess WBC aggregation in whole blood [11] and showed that WBC aggregation is increased in patients with intermittent claudication (Fig. 1) as compared with control individuals [12] . Furthermore, when activated, WBCs adhere not only to themselves (aggregation) but also to the endothelium, thus contributing to the mechanical obstruction of the m icrovessels. This process occurs through complex interactions between adhesion molecules expressed by both leucocytes and endothelial cells. Increased levels of the endothelial cell adhesion molecule E-selectin are significantly increased in patients with claudication, and this increase appears to predict those who will restenose following angioplasty [13] . Levels of soluble E-selectin are also elevated in patients with claudication who are destined to develop critical limb ischaemia over 5 years (Fig. 2) .
The process of atherosclerosis receives major contributions from inflammatory mechanisms. The white blood cell (WBC) count (even in the normal range) is a major predictor for cardiovascular events. WBCs contribute to atherosclerosis through both physical and chemical means. Increased WBC aggregation and levels of cell adhesion molecules are found in claudication and are highest in those predestined to progress to critical limb ischaemia. The products released from WBCs also contribute to the atherosclerotic process. Indirect markers of free radical activity/oxidative stress are increased in intermittent claudication, and are again highest in those predestined to develop critical limb ischaemia. The abnormalities detected are linked to poor endothelial cell function that further promotes vascular disease. The physical obstructive effects of WBCs, combined with the oxidative stress generated by these WBCs and other mechanisms such as reperfusion, have a potential deleterious effect in patients with peripheral arterial disease. We must focus future studies and evolving therapies to this area.
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electron in their outermost shell. Free radicals can be both directly and indirectly thrombotic. Free radicals generated from WBCs can activate other WBCs, causing them to become adherent and rigid. Similarly, free radical damage to platelets causes aggregation, and damage to the red blood cells increases their rigidity. Indirectly, rigid red blood cells are more likely to release adenosine diphosphate, which is a potent platelet aggregant. Released free radicals activated WBCs such as platelet-activating factor will indirectly, once again, activate platelets. Furthermore free radicals interfere with the generation of prostanoids through the arachadonic acid cascade. The presence of free radicals speeds up the formation of those prostanoids, such as thromboxane A 2 ,a potent platelet aggregant and vasoconstrictor. It might be assumed that free radicals increase the production of prostacyclin, a potent platelet disaggregator and vasodilator, but selective i nhibition of prostacyclin synthase occurs through the action of the products of free radical activity (i.e. lipid peroxides). We demonstrated that oxidative stress is present in patients with intermittent claudication as compared with control individuals (Fig. 3) [14] .
Neutrophils and free radicals are the principal mediators of reperfusion injury, which is of particular relevance to the patient with intermittent claudication. Superoxide anions generated during reperfusion through diverse mechanisms may amplify the inflammatory reaction and cause significant vascular injury. In the patient with vascular disease, this can occur during removal of cross-clamping following vascular bypass grafting and during angioplasty [15] . This oxidative stress is linked to increased presentation of cell adhesion molecules, and indeed plasma levels of the soluble E-selectin measured before percutaneous peripheral angioplasty predict restenosis following angioplasty at 1 year [13] .
Further opportunity for reperfusion injury in the patient with claudication occurs during walking. We quantified this using a treadmill and showed lipid peroxide levels to be increased 3 min after cessation of walking on a treadmill in patients with intermittent claudication (Fig. 4 ). An ex vivo c linical study [16] showed that, in such patients, exercise induces reduction in the number of granulocytes that express the adhesion molecules CD11b/CD18 and CD11c/CD18, which are associated with a significant neutropenia. This provides indirect evidence that leucocyte-endothelial interactions occur during exerciseinduced ischaemia in the affected limb. Furthermore, exercise in claudicant patients is characterized by release of thromboxane and interleukin-8 [17, 18] . Interestingly, after patients have trained (treadmill walking for 20 min three times a week for 6 weeks), the reperfusion injury is attenuated (Fig. 5) . Thus, although acute exercise per se increases reperfusion injury (because it increases the activity of all pro-thrombotic mechanisms), regular training attenuates this adverse response, suggesting that the current recommendations for supervised exercise training in this patient group are appropriate.
Link between oxidative stress and endothelial cell function
An important consequence of inflammation and increased oxidative stress is endothelial dysfunction; this results in reduced availability of nitric oxide, which is essential for the integrity of the vessel wall. Using the technique of iontophoresis, we showed that nitric oxide production from the endothelium of patients with claudication is impaired [19] , and indeed the acetylcholine-stimulated vasodilatory reaction is impaired to a greater extent in patients destined to develop critical limb ischaemia over 5 years than in those who remain with stable claudication. Interestingly, nitric oxide production measured using this technique correlates inversely with WBC aggregation, and there appears to be a clear relationship between oxidative stress and subsequent endothelial behaviour.
Cause, consequence or coincidence?
An important issue that must be addressed is whether inflammation and oxidative s tress causes the vascular damage, is a consequence of the vascular damage, or is indeed merely a coincidence. Coincidence is less likely if the abnormalities of inflammation and oxidative stress are present early in the disease (which we demonstrate above) and are present among the risk factors for disease, and if treatment that attenuates those abnormalities produces benefit. Furthermore, if the abnormalities are present in other diseases (e.g. inflammatory disorders) then coincidence is less likely if these patient groups also develop atherosclerosis.
There is no doubt that WBC activation and/or oxidative stress and endothelial dysfunction are associated with risk factors for intermittent claudication. This includes diabetes, smoking and hyperlipidaemia [20, 21] . Furthermore, the endothelial and WBC adhesion molecules are increased in patients with risk factors for claudication such as diabetes [22] . Indeed, oxidative s tress is one of the first abnormalities detected in children with diabetes, in tandem with impaired acetylcholine-induced, endotheliumassociated vasodilator responses [23] . Thus, WBC activation, oxidative s tress and endothelial dysfunction occur in persons with risk factors for intermittent claudication.
We are not yet in a position to claim that treatment of oxidative stress produces benefit in patients with claudication. Certainly, it is possible to attenuate the changes of oxidative s tress by pre-treatment with antioxidants (vitamins C and E; Fig. 6 ) and allopurinol (a xanthine oxidase inhibitor) [24] , and lipid lowering in claudication significantly improves nitric oxide production [19] . Thus, it is possible to attenuate the changes produced by oxidative stress. However, further studies are required in this area.
There is no doubt that the same changes as described above a re present in inflammatory diseases [25] . These include such diseases as rheumatoid arthritis and systemic sclerosis. If our hypothesis that these changes mediate atherosclerosis is correct, then atherosclerosis should also be found in those patients, and indeed we have found this to be the case (Fig. 7) [26] . Furthermore, it is well recognized that cardiovascular mortality in rheumatic diseases is three times the standard mortality ratio in rheumatoid arthritis, 4·2 times in systemic sclerosis and 4·5 times, on average, in systemic lupus erythematosus. Thus, we believe that there is convincing evidence that patients with similar inflammatory changes in their blood secondary to classic inflammatory disorders are also at increased risk for premature cardiovascular events and mortality.
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Figure 6
Antioxidant therapy prevents oxidative stress induced by percutaneous transluminal angioplasty in patients with peripheral arterial disease. Left=no treatment; right=antioxidant therapy; MDA= malondialdehyde.
Conclusion
In conclusion, it has been recognized for some years that the WBC and inflammatory processes are important mediators of the atherosclerotic process. The oxidative s tress generated from WBCs and through other mechanisms such as reperfusion has a potential deleterious effect in patients with intermittent claudication. Not only is there evidence for increased oxidative stress in such patients, but also the higher the levels the more likely the patient is to proceed to critical limb ischaemia. Inflammation appears to be important in atherogenesis in the patient with intermittent claudication. We must focus future studies and evolving therapies to this area. 
